drugset / Trial / NCT06473948

To Assess the Effects of Single Dose of JMKX001899 on QTc Interval in Healthy Subjects

NCT06473948

Phase 1 Unknown 27 enrolled Jemincare
RandomizedParallel-groupDouble-blindBasic science

Summary

Study to assess the effect of JMKX001899 on QTc interval in healthy volunteers

Timeline

Start
2024-07-10
Primary completion
2024-09-24
Completion
2025-02-27

Drugs

EvaluationDrugModalityDoseRoute
Subject JMKX001899 Unknown 500 mg Oral
Subject JMKX001899 Unknown 750 mg Oral
Subject JMKX001899 Unknown 1000 mg Oral

Indications